tirzepatide march 19th FDA ban on compounded tirzepatide: Switch to name brand medications Lilly, Novo Fight Weight Loss
Description
Participants reported decreased food cravings and improved control over eating
Lee: Patient behavior can absolutely play a role
For most people focused primarily on weight loss (which is the majority of the GLP-1 user population), tirzepatide is the stronger option based on current evidence
What This Means Practically Tizaro users rely on the validated mechanism of tirzepatide itself
